Full history for every metric is available with a Kvantra account
Danish Aerospace Company AS (DAC.CO)
Key financial summary
Financials in DKK| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | DKK m | 22 | 20 | 24 | 32 | 19 | 19 | 20 |
| Operating profit | DKK m | -3 | -3 | |||||
| Net profit | DKK m | 0 | 0 | -0 | 2 | -4 | -4 | -4 |
| EPS reported | DKK | -0.27 | -0.27 | |||||
| Operating cashflow per share | DKK | 0.09 | 0.09 | |||||
| Capex per share | DKK | 0.00 | 0.00 | |||||
| FCF per share | DKK | 0.08 | 0.08 | |||||
| Free cash flow | DKK m | 1 | 1 | |||||
| Net debt | DKK m | 13 | 13 | |||||
| Book value equity | DKK m | 5 | 5 | |||||
| Book value per share | DKK | 0.36 | 0.36 | |||||
| Number of shares | m | 13.15 | 13.15 | |||||
| DPS (TTM paid) | DKK | 0.00 | 0.00 |
Financial summary
Financials in DKK| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | - | - | |||||
| P/B LTM | x | 19.96 | 7.06 | |||||
| P/S LTM | x | 4.98 | 1.69 | |||||
| P/FCF LTM | x | 86.94 | 30.75 | |||||
| EV/EBITDA LTM | x | -37.66 | -18.17 | |||||
| EV/Sales LTM | x | 5.69 | 2.37 | |||||
| Earnings Yield LTM | % | -3.72% | -8.78% | |||||
| FCF Yield | % | 1.15% | 3.25% | |||||
| Quality | ||||||||
| ROE | % | -74.27% | -55.94% | |||||
| ROIC | % | -12.72% | -13.09% | |||||
| Operating margin | % | -18.00% | -17.73% | |||||
| Gross margin | % | -17.60% | 22.21% | |||||
| FCF/Sales | % | 5.73% | 5.50% | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | - | - | |||||
| Sales Growth YoY | % | +0.13% | +0.13% | |||||
| Net Income Growth YoY | % | - | - | |||||
| FCF Growth | % | -55.88% | -55.88% | |||||
| Operating Profit Growth | % | - | - | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | 0.00% | 0.00% | |||||
| Dividend Growth | % | 0.00% | 0.00% | |||||
| Payout Ratio | % | 0.00% | 0.00% | |||||
| FCF/Debt | x | 0.08 | 0.08 | |||||
| Net Debt/EBITDA | x | -4.69 | -5.22 | |||||
| EBIT/Net interest | x | -1.60 | -1.11 | |||||
| Net debt/market cap | % | 14.24% | 40.26% | |||||
| Net debt/Equity | x | 2.84 | 2.84 | |||||
| Gross debt/equity | x | 2.85 | 2.85 | |||||
Company overview
Danish Aerospace Company A/S designs, develops, manufactures, and sells medical monitoring and exercise equipment. It offers agile data analyzer and monitor, a medical software that supports loading data over a network connection; portable pulmonary function systems for use in the areas of respiratory, cardiovascular, and metabolic physiology; cycle ergometer with vibration isolation and stabilization system, a recumbent bicycle that provides aerobic exercise for the harmful physiological effects of exposure to microgravity; advanced respiratory monitoring systems; European enhanced exploration exercise devices; shuttle ergometer; and flight ergometer, the next generation space ergometer. The company provides respiratory monitoring systems-II equipment, a photo- and magnetoacoustic multi-gas analyzer for performing non-invasive cardiovascular and pulmonary measurements; and European gas delivery system, a specially developed gas cylinder used for calibration and measurement of equipment and/or as breathing gases for use in space. The company was founded in 1988 and is based in Odense, Denmark.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Danish Aerospace Company AS (DAC.CO)
Danish Aerospace Company A/S designs, develops, manufactures, and sells medical monitoring and exercise equipment. It offers agile data analyzer and monitor, a medical software that supports loading data over a network connection; portable pulmonary function systems for use in the areas of respiratory, cardiovascular, and metabolic physiology; cycle ergometer with vibration isolation and stabilization system, a recumbent bicycle that provides aerobic exercise for the harmful physiological effects of exposure to microgravity; advanced respiratory monitoring systems; European enhanced exploration exercise devices; shuttle ergometer; and flight ergometer, the next generation space ergometer. The company provides respiratory monitoring systems-II equipment, a photo- and magnetoacoustic multi-gas analyzer for performing non-invasive cardiovascular and pulmonary measurements; and European gas delivery system, a specially developed gas cylinder used for calibration and measurement of equipment and/or as breathing gases for use in space. The company was founded in 1988 and is based in Odense, Denmark.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free